Rosalind Watts is a clinical psychologist and clinical lead at the Psychedelics Research Group at Imperial College London. She is also known for developing the ‘Accept, Connect, Embody’ psychedelic therapy model.
Rosalind worked as clinical psychologist and practised psychotherapy for the NHS (UK) from 2006 to 2012.
She is currently the clinical lead at the Psychedelics Research Group at Imperial College London. There she works together with, among others, David Nutt and Robin Carhart-Harris. She also co-facilitates a monthly Psychedelic Integration group with Michelle Baker Jones.
She is a member of the advisory board of Synthesis.
Notable Research Papers
- The use of the psychological flexibility model to support psychedelic assisted therapy (Watts & Luoma, 2020)
- Psychedelics and the essential importance of context (Carhart-Harris et al., 2018)
- Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression (Watts et al., 2017)
Find more on Google Scholar or PubMed
- The whole-planet view (Aeon, September 2019)
- Researching Psilocybin’s Effects on Depression – Dr. Rosalind Watts (YCombinator, March 2018)
- Can Magic Mushrooms Unlock Depression? | Rosalind Watts | TEDxOxford (TEDxOxford, February 2017)
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)
Guiding the Unbound Mind
Guiding the Unbound Mind: What Every Practitioner Must Know About Working With Psychedelics, is an on-demand expert forum. This event is available at no charge and is designed to help practitioners safely and effectively incorporate psychedelics into their treatment protocols.